Metheptazine
Clinical data
Other namesMetheptazine
ATC code
  • none
Identifiers
  • methyl 1,2-dimethyl-4-phenylazepane-4-carboxylate
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC16H23NO2
Molar mass261.365 g·mol−1
3D model (JSmol)
  • O=C(OC)C2(c1ccccc1)CC(N(C)CCC2)C
  • InChI=1S/C16H23NO2/c1-13-12-16(15(18)19-3,10-7-11-17(13)2)14-8-5-4-6-9-14/h4-6,8-9,13H,7,10-12H2,1-3H3 checkY
  • Key:RAAFYFKWMRWOIT-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Metheptazine is an opioid analgesic from the phenazepane family. It was developed by American Home Products in the 1950s.[1]

Metheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.

Metheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[2] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.

References

  1. ^ US 3316244, Bell SC, Childress SJ, "Process for the preparation of hexahydro-1,3-dimethyl-4-phenylazepine-4-carboxylic acid, ethyl ester", issued 25 April 1967, assigned to American Home Products Corporation. 
  2. ^ "Conversion Factors for Controlled Substances". U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division.


Categories